CymaBay Therapeutics: Q4 Earnings Insights

CymaBay Therapeutics CBAY reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

CymaBay Therapeutics missed estimated earnings by 30.77%, reporting an EPS of $-0.34 versus an estimate of $-0.26.

Revenue was down $0.00 from the same period last year.

Last quarter the company missed on EPS by $0.07 which was followed by a 0.93% increase in the share price the next day.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.